There were 1,335 press releases posted in the last 24 hours and 313,222 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Mesoblast Receives Complete Response Letter From the FDA for Biologics License Application for Steroid-Refractory Acute Graft Versus Host Disease in Children

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image